- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.75 Å
- Oligo State
- homo-tetramer
- Ligands
- 2 x JVZ: (2~{S})-1-(benzimidazol-1-yl)-3-(2,3-dihydro-1~{H}-inden-5-yloxy)propan-2-ol(Non-covalent)
- 4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
NAD.2: 27 residues within 4Å:- Chain A: G.17, I.18, I.19, S.23, I.24, A.25, F.44, L.66, D.67, V.68, Q.69, S.97, I.98, G.99, F.100, I.125, M.150, D.151, F.152, M.164, K.168, A.194, G.195, P.196, I.197, T.199, M.202
23 PLIP interactions:23 interactions with chain A- Hydrophobic interactions: A:I.24, A:F.152, A:F.152, A:A.194
- Hydrogen bonds: A:S.23, A:I.24, A:D.67, A:D.67, A:V.68, A:I.98, A:G.99, A:K.168, A:I.197, A:I.197, A:T.199
- Water bridges: A:I.18, A:F.44, A:F.44, A:S.97, A:S.97, A:I.98, A:G.99
- pi-Stacking: A:F.44
NAD.3: 28 residues within 4Å:- Chain B: G.17, I.18, I.19, S.23, I.24, A.25, F.44, L.66, D.67, V.68, Q.69, S.97, I.98, G.99, F.100, I.125, M.150, D.151, F.152, Y.161, M.164, K.168, A.194, G.195, P.196, I.197, T.199, M.202
21 PLIP interactions:21 interactions with chain B- Hydrophobic interactions: B:F.152, B:A.194
- Hydrogen bonds: B:S.23, B:I.24, B:D.67, B:D.67, B:V.68, B:I.98, B:G.99, B:K.168, B:I.197, B:I.197
- Water bridges: B:I.18, B:T.20, B:F.44, B:F.44, B:S.97, B:S.97, B:I.98, B:T.199
- pi-Stacking: B:F.44
NAD.5: 27 residues within 4Å:- Chain C: G.17, I.18, I.19, S.23, I.24, A.25, F.44, L.66, D.67, V.68, Q.69, S.97, I.98, G.99, F.100, I.125, M.150, D.151, F.152, M.164, K.168, A.194, G.195, P.196, I.197, T.199, M.202
22 PLIP interactions:22 interactions with chain C- Hydrophobic interactions: C:I.24, C:F.152, C:F.152, C:A.194
- Hydrogen bonds: C:S.23, C:I.24, C:D.67, C:V.68, C:I.98, C:G.99, C:K.168, C:I.197, C:I.197, C:T.199
- Water bridges: C:I.18, C:F.44, C:F.44, C:S.97, C:S.97, C:I.98, C:G.99
- pi-Stacking: C:F.44
NAD.6: 28 residues within 4Å:- Chain D: G.17, I.18, I.19, S.23, I.24, A.25, F.44, L.66, D.67, V.68, Q.69, S.97, I.98, G.99, F.100, I.125, M.150, D.151, F.152, Y.161, M.164, K.168, A.194, G.195, P.196, I.197, T.199, M.202
20 PLIP interactions:20 interactions with chain D- Hydrophobic interactions: D:F.152, D:A.194
- Hydrogen bonds: D:S.23, D:I.24, D:D.67, D:V.68, D:I.98, D:G.99, D:K.168, D:I.197, D:I.197
- Water bridges: D:I.18, D:T.20, D:F.44, D:F.44, D:S.97, D:S.97, D:I.98, D:T.199
- pi-Stacking: D:F.44
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kamsri, P. et al., Discovery of New and Potent InhA Inhibitors as Antituberculosis Agents: Structure-Based Virtual Screening Validated by Biological Assays and X-ray Crystallography. J.Chem.Inf.Model. (2020)
- Release Date
- 2019-12-25
- Peptides
- Enoyl-[acyl-carrier-protein] reductase [NADH]: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.75 Å
- Oligo State
- homo-tetramer
- Ligands
- 2 x JVZ: (2~{S})-1-(benzimidazol-1-yl)-3-(2,3-dihydro-1~{H}-inden-5-yloxy)propan-2-ol(Non-covalent)
- 4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kamsri, P. et al., Discovery of New and Potent InhA Inhibitors as Antituberculosis Agents: Structure-Based Virtual Screening Validated by Biological Assays and X-ray Crystallography. J.Chem.Inf.Model. (2020)
- Release Date
- 2019-12-25
- Peptides
- Enoyl-[acyl-carrier-protein] reductase [NADH]: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B